The Use of Antidepressants, Anxiolytics, and Hypnotics in People with Type 2 Diabetes and Patterns Associated with Use: The Hoorn Diabetes Care System Cohort

Objective. With depression being present in approximately 20% of people with type 2 diabetes mellitus (T2DM), we expect equally frequent prescription of antidepressants, anxiolytics, and hypnotics. Nevertheless, prescription data in people with T2DM is missing and the effect of depression on glycaem...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomed Res Int
Autors principals: Mast, R., Rauh, S. P., Groeneveld, L., Koopman, A. D., Beulens, J. W. J., Jansen, A. P. D., Bremmer, M., van der Heijden, A. A. W. A., Elders, P. J., Dekker, J. M., Nijpels, G., Hugtenburg, J. G., Rutters, F.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5292378/
https://ncbi.nlm.nih.gov/pubmed/28232942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5134602
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars